Lexicon Pharmaceuticals

Lexicon Pharmaceuticals

Employees:
170
Market Cap:
$1.59 billion
Revenue:
$83.17 million
5 Year Trend:
114.1%
Net Income:
$-140.42 million
NASDAQ:
LXRX

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovering and developing breakthrough treatments for human disease. The company was founded in 1995 in The Woodlands, Texas under the name Lexicon Genetics, Incorporated by co-founders Arthur T Sands, Ray B Webb and. Wikipedia

Lexicon Pharmaceuticals

Employees:
170
Market Cap:
$1.59 billion
Revenue:
$83.17 million
5 Year Trend:
114.1%
Net Income:
$-140.42 million
NASDAQ:
LXRX

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovering and developing breakthrough treatments for human disease. The company was founded in 1995 in The Woodlands, Texas under the name Lexicon Genetics, Incorporated by co-founders Arthur T Sands, Ray B Webb and. Wikipedia